Processa Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q1 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Processa Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2014 to Q3 2024.
  • Processa Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 19.7 %, a 26.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 19.7 +4.15 +26.7% Sep 30, 2024
Q2 2024 16.1 +3.05 +23.4% Jun 30, 2024
Q1 2024 12.3 +0.65 +5.6% Mar 31, 2024
Q4 2023 15.7 +8.11 +107% Dec 31, 2023
Q3 2023 15.6 +9.78 +169% Sep 30, 2023
Q2 2023 13 +7.37 +130% Jun 30, 2023
Q1 2023 11.6 +6.14 +112% Mar 31, 2023
Q4 2022 7.57 +1.67 +28.3% Dec 31, 2022
Q3 2022 5.79 -1.43 -19.8% Sep 30, 2022
Q2 2022 5.66 -5.83 -50.7% Jun 30, 2022
Q1 2022 5.47 -12.2 -69.1% Mar 31, 2022
Q4 2021 5.91 -23.7 -80% Dec 31, 2021
Q3 2021 7.22 -40.8 -85% Sep 30, 2021
Q2 2021 11.5 -25.3 -68.7% Jun 30, 2021
Q1 2021 17.7 -15 -45.9% Mar 31, 2021
Q4 2020 29.6 -1.78 -5.67% Dec 31, 2020
Q3 2020 48 +18.3 +61.6% Sep 30, 2020
Q2 2020 36.8 +6.38 +21% Jun 30, 2020
Q1 2020 32.7 +3.61 +12.4% Mar 31, 2020
Q4 2019 31.4 -5.9 -15.8% Dec 31, 2019
Q3 2019 29.7 -18.9 -38.9% Sep 30, 2019
Q2 2019 30.4 -30.2 -49.9% Jun 30, 2019
Q1 2019 29.1 -182 -86.2% Mar 31, 2019
Q4 2018 37.3 +204 Dec 31, 2018
Q3 2018 48.6 +120 Sep 30, 2018
Q2 2018 60.6 +138 Jun 30, 2018
Q1 2018 211 +288 Mar 31, 2018
Q4 2017 -167 -90 -117% Dec 31, 2017
Q3 2017 -71.2 +60.9 +46.1% Sep 30, 2017
Q2 2017 -77.4 +65.7 +45.9% Jun 30, 2017
Q1 2017 -77.1 +89.4 +53.7% Mar 31, 2017
Q4 2016 -76.8 +278 +78.4% Dec 31, 2016
Q3 2016 -132 +596 +81.9% Sep 30, 2016
Q2 2016 -143 -1.87K -108% Jun 30, 2016
Q1 2016 -167 -503 -150% Mar 31, 2016
Q4 2015 -355 -652 -219% Dec 31, 2015
Q3 2015 -728 -981 -389% Sep 30, 2015
Q2 2015 1.73K +1.61K +1354% Jun 30, 2015
Q1 2015 336 +220 +190% Mar 31, 2015
Q4 2014 297 Dec 31, 2014
Q3 2014 252 Sep 30, 2014
Q2 2014 119 Jun 30, 2014
Q1 2014 116 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.